On Tuesday, the EU Commission approved the drug Kesimpta, which was developed by Genmab, as a treatment for sclerosis.
Thus, Genmab's partner Novartis, which currently has the rights to the drug, can start launching the drug in Europe. Hopefully, this will pan out as well as it has in the US, where the drug was approved in late August last year.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
CHMP recommends nine new drugs, rejects one
Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.
WS Audiology still chewing over listing of online hearing company
The hearing giant is still mulling over the independent listing of Hear.com.
CEO at WSA: No clarity on EQT exit plans yet
The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.
Oticon: Covid-19 led to debates about product launches
The unpredictable world situation in the spring of 2020 meant that the timing of product launches was frequently discussed at Demant-owned Oticon, located in Denmark.
EU Commission ends Danish HERA dreams – but could provide new opportunities for the pharmaceutical industry
With a budget potentially exceeding EUR 47.1bn (DKK 350bn), the EU Commission wants to establish a new agency to ward against future health crises. While the financial makeup is uncertain, good news for future clinical trials might be on the way.
Principal Scientist, In Vivo Pharmacology 
Project Manager, Adcendo ApS 
Analytical Specialist – Product Lifecycle Management (PLM), Orifarm 
Principal Scientist, Protein Drug Discovery & Development - Y-mAbs Therapeutics A/S 
A tech-savvy Project Manager Oncology (m/f/x) with a passion for communication and cross-functional collaboration - Daiichi-Sankyo 
Scientific Advisor infectious disease - Vaccibody 
Associate Director/Senior Manager, Global Regulatory Affairs Project Lead - Genmab 
KLIFO is looking for an experienced and skilled Proposal Manager for one of our offices in Denmark, Sweden or Germany 
Director of Communications – Evaxion Biotech 
Clinical Research Specialist, Post Market Clinical Development - Ambu 
Medical Scientific Liaison Dermo aesthetic, IBSA 
Medical Director (diabetes and obesity) - Zealand Pharma